Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.

Breast cancer metastasis: markers and models. Nat Rev Cancer (2005) 9.93

HMDB 3.0--The Human Metabolome Database in 2013. Nucleic Acids Res (2012) 9.21

Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res (1992) 9.02

Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc (2007) 5.92

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys (2007) 5.07

Breast cancer metastasis to the central nervous system. Am J Pathol (2005) 3.30

A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis (1999) 2.93

Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Ophthal Plast Reconstr Surg (2001) 2.82

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Neurology (2014) 2.45

Epidemiology of brain metastases. Curr Oncol Rep (2012) 2.09

Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int (2011) 1.64

matNMR: a flexible toolbox for processing, analyzing and visualizing magnetic resonance data in Matlab. J Magn Reson (2007) 1.45

Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol (1999) 1.45

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1. Ann Oncol (2001) 1.28

An integrated functional genomic study of acute phenobarbital exposure in the rat. BMC Genomics (2010) 1.19

Brain metastases. Neurologist (2004) 1.16

Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol (2000) 1.14

Molecular MRI enables early and sensitive detection of brain metastases. Proc Natl Acad Sci U S A (2012) 1.10

Rebuilding cancer metastasis in the mouse. Mol Oncol (2013) 1.08

Urinary metabolomic signature of esophageal cancer and Barrett's esophagus. World J Surg Oncol (2012) 1.04

Magnetic resonance imaging and computed tomography in the diagnoses of brain metastases of lung cancer. Lung Cancer (2004) 1.01

Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods. Ann Oncol (2011) 0.99

Study of cytokine induced neuropathology by high resolution proton NMR spectroscopy of rat urine. FEBS Lett (2004) 0.90

A robust automatic phase correction method for signal dense spectra. J Magn Reson (2013) 0.86

Structural and functional effects of metastases in rat brain determined by multimodal MRI. Int J Cancer (2013) 0.86

The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis. Cancer Imaging (2014) 0.85

Ultrasonography-guided intracardiac injection: an improvement for quantitative brain colonization assays. Am J Pathol (2013) 0.79

T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS. J Cereb Blood Flow Metab (2014) 0.81

Detection of brain pathology by magnetic resonance imaging of iron oxide micro-particles. Methods Mol Biol (2011) 0.77

Circulating endothelial cell-derived extracellular vesicles mediate the acute phase response and sickness behaviour associated with CNS inflammation. Sci Rep (2017) 0.75